Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -10.69%9.48B | 16.20%20.63B | 41.52%10.62B | 14.07%17.76B | -7.38%7.5B | 9.29%15.56B | 25.37%8.1B | 68.92%14.24B | 78.80%6.46B | -10.28%8.43B |
| Operating income | -10.69%9.48B | 16.20%20.63B | 41.52%10.62B | 14.07%17.76B | -7.38%7.5B | 9.29%15.56B | 25.37%8.1B | 68.92%14.24B | 78.80%6.46B | -10.28%8.43B |
| Cost of sales | 12.21%-8.68B | -14.09%-19.06B | -39.10%-9.89B | -18.13%-16.71B | -1.05%-7.11B | -23.03%-14.14B | -36.06%-7.04B | -63.02%-11.49B | -66.39%-5.17B | 9.37%-7.05B |
| Operating expenses | 12.21%-8.68B | -14.09%-19.06B | -39.10%-9.89B | -18.13%-16.71B | -1.05%-7.11B | -23.03%-14.14B | -36.06%-7.04B | -63.02%-11.49B | -66.39%-5.17B | 9.37%-7.05B |
| Gross profit | 9.90%804.36M | 49.74%1.57B | 85.01%731.91M | -26.26%1.05B | -62.94%395.61M | -48.18%1.42B | -17.39%1.07B | 99.07%2.75B | 154.79%1.29B | -14.63%1.38B |
| Selling expenses | 16.15%-126.01M | -19.24%-279.11M | -55.60%-150.28M | 11.39%-234.08M | 20.72%-96.59M | -28.60%-264.18M | -8.81%-121.83M | -77.70%-205.43M | -159.34%-111.96M | -29.01%-115.6M |
| Administrative expenses | 7.20%-322.04M | -18.30%-763.94M | -36.19%-347.03M | -2.18%-645.78M | 17.87%-254.8M | -2.90%-632.03M | -16.55%-310.25M | -50.07%-614.24M | -26.68%-266.2M | 7.54%-409.31M |
| Special items of operating profit | -28.01%139.52M | 22.27%441.79M | -27.34%193.8M | -16.63%361.32M | 2.57%266.71M | 0.26%433.37M | 14.19%260.02M | 70.31%432.27M | 156.28%227.71M | 29.67%253.81M |
| Operating profit | 15.74%495.84M | 82.70%971.09M | 37.78%428.39M | -44.70%531.52M | -65.28%310.94M | -59.28%961.11M | -21.58%895.46M | 112.79%2.36B | 233.14%1.14B | -13.37%1.11B |
| Financing cost | 22.50%-66.18M | -10.24%-132.49M | -44.73%-85.39M | 44.44%-120.18M | 54.24%-59M | 19.57%-216.31M | 13.17%-128.92M | -37.09%-268.93M | -68.52%-148.46M | 8.67%-196.18M |
| Earning before tax | 25.26%429.66M | 103.87%838.6M | 36.15%343.01M | -44.77%411.33M | -67.13%251.94M | -64.39%744.8M | -22.84%766.54M | 129.06%2.09B | 290.09%993.38M | -14.31%913.07M |
| Tax | -240.83%-52.97M | -56.55%-90.7M | 69.08%-15.54M | 34.89%-57.94M | 37.33%-50.26M | 73.18%-88.98M | 49.13%-80.19M | -152.11%-331.75M | -438.27%-157.64M | 38.04%-131.59M |
| After-tax profit from continuing operations | 15.03%376.69M | 111.63%747.9M | 62.37%327.47M | -46.11%353.4M | -70.62%201.68M | -62.73%655.82M | -17.87%686.35M | 125.18%1.76B | 270.84%835.74M | -8.41%781.48M |
| Earning after tax | 15.03%376.69M | 111.63%747.9M | 62.37%327.47M | -46.11%353.4M | -70.62%201.68M | -62.73%655.82M | -17.87%686.35M | 125.18%1.76B | 270.84%835.74M | -8.41%781.48M |
| Profit attributable to shareholders | 15.03%376.69M | 111.63%747.9M | 62.37%327.47M | -46.11%353.4M | -70.62%201.68M | -62.73%655.82M | -17.87%686.35M | 125.18%1.76B | 270.84%835.74M | -8.41%781.48M |
| Basic earnings per share | 20.00%0.18 | 105.88%0.35 | 50.00%0.15 | -45.16%0.17 | -68.75%0.1 | -62.65%0.31 | -20.00%0.32 | 124.32%0.83 | 263.64%0.4 | -7.50%0.37 |
| Diluted earnings per share | 20.00%0.18 | 105.88%0.35 | 50.00%0.15 | -45.16%0.17 | -68.75%0.1 | -62.65%0.31 | -20.00%0.32 | 124.32%0.83 | 263.64%0.4 | -7.50%0.37 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.